Pediatrics
This session provides a contemporary overview of the role of radiation therapy in the treatment of pediatric malignancies. The session reviews the diseases in which radiation therapy is used including the disease presentations, workups, treatment algorithms and radiation treatment details. It covers fields, doses, fractionations, common short term side effects, and subacute and late risks of treatment. The session briefly discusses in which disease proton therapy should be considered.
Target Audience
The meeting is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, radiation therapists, radiation dosimetrists, nurses and all other health professionals involved in the field of radiation oncology.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
- Compare and contrast the fields, dose, and fractionation of radiation therapy for localized infratentorial ependymoma vs. average risk medulloblastoma.
- Outline the treatment schema, radiation fields, radiation dose and radiation fractionation for parameningeal rhabdomyosarcoma.
- List at least two pediatric cancer scenarios in which photon radiation is often preferable to proton radiation.
Planning Committee Disclosures
The person(s) above served as the developer(s) of this activity. Additionally, ASTRO Education Committee had control over the content of this activity.
All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 1.50 AMA PRA Category 1 Credit™
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.